Human sensory-like neuron cultivation - an optimized protocol
Nicole Michelle Schottmann, Julia GrüneriD, Frederik BäriD, Franziska Karl‐Schöller, Sabrina OerteriD, Nurcan ÜçeyleriD
Abstract
IntroductionReprogramming of human induced pluripotent stem cells (iPSC) and their differentiation into specific cell types, such as induced sensory-like neurons (iSN), are critical for disease modeling and drug testing. However, the variability of cell populations challenges reliability and reproducibility. While various protocols for iSN differentiation exist, development of non-iSN cells in these cultures remains an issue. Therefore, standardization of protocols is essential. This study aimed to improve iSN culture conditions by reducing the number of non-iSN cells while preserving survival and quality of iSN. MethodsiSN were differentiated from a healthy control iPSC line using an established protocol. Interventions for protocol optimization included floxuridine (FdU) or 1-{beta}-D-arabinofuranosyl-cytosin-hydrochlorid (AraC) treatment, Magnetic-Activated Cell Sorting (MACS), early cell passaging, and replating. Cell viability and iSN-to-total-cell-count ratio were assessed using a luminescent assay and immunocytochemistry, respectively. ResultsPassaging of cells during differentiation did not increase the iSN-to-total-cell-count ratio, and MACS of immature iSN led to neuronal blebbing and reduced the iSN-to-total-cell-count ratio. Treatment with high concentrations and prolonged incubation of FdU or AraC resulted in excessive cell death. However, treatment with 10 M FdU for 24 h post-differentiation showed the most selective targeting of non-iSN cells, leading to an increase in the iSN-to-total-cell count ratio without compromising the viability or functionality of the iSN population. Replating of iSN shortly after seeding also helped to reduce non-iSN cells. ConclusionIn direct comparison to other methods, treatment with 10 M FdU for 24 h after differentiation represents a promising approach to improve iSN culture purity, offering a potential benefit for downstream applications in disease modeling and drug discovery. However, further investigations involving multiple iPSC lines and optimization of protocol parameters are warranted to fully exploit the potential of this method and enhance its reproducibility and applicability. Overall, this study provides valuable insights into optimizing culture conditions for iSN differentiation and highlights the importance of standardized protocols in iPSC-based research.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.14
- Field percentile
- 40th percentile
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Framework for NGN1-Induced Sensory Neuron Differentiation for Disease Modelling and Drug Screening
Anika Neureiter, Marlene Menke, … Angelika Lampert·bioRxiv·Sep 14, 2026
- Satellite glial contact enhances differentiation and maturation of human iPSC-derived sensory neurons
Chelsey Jenna LeBlang, Maria F. Pazyra‐Murphy, … Rosalind A. Segal·Stem Cell ReportsPeer-reviewed·Sep 23, 2025
- Differentiation of human induced pluripotent stem cells into cortical neural stem cells
Alexandra S. Neaverson, Malin H. L. Andersson, … Sebastian S. Gerety·Frontiers in Cell and Developmental BiologyPeer-reviewed·Jan 5, 2023
- Polyclonal sensory neuron derivation from iPSCs as an efficient alternative to single clone strategies for pain relevant in vitro models
Anika Neureiter, Luise Ruessmann, … Angelika Lampert·bioRxiv·Sep 14, 2026
- In vitro programming and pseudounipolarization of human iPSC-derived sensory neurons
Pascal Röderer, Ana Catarina Costa, … Oliver Brüstle·bioRxiv·Sep 21, 2026
- Differentiation protocol and maturation shape the axial identity and synaptic state in human iPSC-derived spinal motor neurons
Alba Sansa, Vladimir Zhemkov, … Clive Niels Svendsen·bioRxiv·Sep 17, 2026